Intra-Articular Injection Therapies for Osteoarthritis Management

Intra-articular injection therapies have become central to the symptomatic management of osteoarthritis by delivering bioactive agents directly into affected joints. Corticosteroids remain the most commonly employed compounds, offering prompt anti-inflammatory and analgesic effects yet limited durability. Viscosupplements such as hyaluronic acid aim to restore synovial fluid properties and joint lubrication, though clinical benefits are modest and variable. Biologic preparations including platelet-rich plasma and mesenchymal cell derivatives are emerging as strategies to modulate tissue repair and inflammatory pathways. Advanced drug delivery systems, notably polymeric microsphere formulations, seek to extend therapeutic residence and reduce injection frequency. While intervention efficacy is well documented in the short term, long-term structural impact, optimal dosing intervals and safety considerations—such as infection risk and potential cartilage or meniscal alterations—continue to drive global research efforts towards more personalised, durable and disease-modifying regimens for diverse patient populations.

Research from Nature Portfolio

Recent studies have demonstrated that intra-articular corticosteroid injections in knee osteoarthritis result in transient alterations in joint structure. A nested case–control analysis using magnetic resonance imaging revealed a significant, though temporary, reduction in medial meniscal thickness and joint space width in the year of injection, while cartilage volume and patient-reported pain scores remained unchanged. These findings suggest that a single corticosteroid administration is structurally safe but prompts consideration of the clinical relevance of meniscal changes in long-term management.

Intra-Articular Injection Therapies for Osteoarthritis Management publication trend

The graph below shows the total number of articles in intra-articular injection therapies for osteoarthritis management across all publications each year (not limited to Nature Index journals).

Technical terms

Intra-articular injection: A procedure in which therapeutic agents are delivered directly into a joint space to target local pathology.

Corticosteroid: A synthetic anti-inflammatory compound that reduces synovitis and pain in osteoarthritic joints.

Hyaluronic acid: A viscoelastic supplement intended to restore synovial fluid viscosity and improve joint lubrication.

Platelet-rich plasma (PRP): A concentrated suspension of autologous platelets used to enhance tissue repair and modulate inflammation.

Microsphere formulation: A drug delivery system in which active compounds are encapsulated in polymeric particles for extended intra-articular release.

Network meta-analysis: A statistical method that compares multiple interventions across trials by integrating direct and indirect evidence.

References

1. Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis. Osteoarthritis and Cartilage (2024).
2. Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis. Arthritis & Rheumatology (2017).
3. Effects of recurrent intra-articular corticosteroid injections for osteoarthritis at 3 months and beyond: a systematic review and meta-analysis in comparison to other injectables. Osteoarthritis and Cartilage (2022).
4. Intra-articular corticosteroid knee injection induces a reduction in meniscal thickness with no treatment effect on cartilage volume: a case–control study. Scientific Reports (2020).